SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-23-057137
Filing Date
2023-07-14
Accepted
2023-07-14 17:00:09
Documents
12
Period of Report
2023-05-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A ea181759-8ka1_abvcbio.htm   iXBRL 8-K/A 23680
  Complete submission text file 0001213900-23-057137.txt   196895

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20230526.xsd EX-101.SCH 2983
3 XBRL LABEL FILE abvc-20230526_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abvc-20230526_pre.xml EX-101.PRE 22375
6 EXTRACTED XBRL INSTANCE DOCUMENT ea181759-8ka1_abvcbio_htm.xml XML 3683
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40700 | Film No.: 231089674
SIC: 2834 Pharmaceutical Preparations